Side by side
How the two compare across structure, mechanism studied, evidence and regulatory status, based on published research.
| Property | Wolverine Blend | KLOW Blend |
|---|---|---|
| Class | Two-peptide research blend | Multi-peptide research blend |
| Research category | tissue repair models | tissue repair, dermal and inflammation models |
| Evidence level | Very low | Very low |
| Overall status | Not approved — research | Not approved — research |
| FDA | Not approved | Not approved |
| EMA | Not approved | Not approved |
| WADA | Contains prohibited components (S0 / S2) | Contains prohibited components (S0 / S2) |
| Mechanism studied | BPC-157 + TB-500 → Angiogenesis & actin dynamics → Cell migration → Tissue remodelling | KLOW blend → Matrix, actin & NF-κB pathways → Repair signalling → Tissue remodelling models |
| Molecular weight | — | — |
| Sizes in stock | , |
Where the research overlaps
Both compounds are studied within Research Blends and Tissue Repair research. Wolverine Blend is classed as two-peptide research blend, while KLOW Blend is multi-peptide research blend. Evidence is rated very low for Wolverine Blend and very low for KLOW Blend.
FOR RESEARCH USE ONLY.Not for human or veterinary use. Not intended to diagnose, treat, cure, or prevent any disease.